SCHEMBL17346244

SCHEMBL17346244

CN(CCCNCCCSCc1ccccc1)C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.40
SLC18A3 Q16572 1/20 0.40
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GRIN2B Q13224 4/20 0.38
TP53 P04637 3/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ACHE P22303 2/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
GRIN1 Q05586 2/20 0.37
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
BCHE P06276 1/20 0.37
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346063 0.99 SLC18A3 (0.40) SIGMAR1SLC18A3USP2HPGDHSD17B10
SCHEMBL17345886 0.88 HPGD (0.40) SLC18A3USP2HPGDHSD17B10KDM4E
SCHEMBL17346321 0.88 SIGMAR1 (0.42) SIGMAR1USP2HPGDHSD17B10SMN1; SMN2
SCHEMBL17345896 0.86 HPGD (0.39) SLC18A3USP2HPGDHSD17B10KDM4E
SCHEMBL17346340 0.86 SIGMAR1 (0.40) SIGMAR1HPGDSMN1; SMN2LMNA
SCHEMBL17346152 0.86 GRIN2B (0.40) SIGMAR1USP2HPGDHSD17B10GRIN2B
SCHEMBL17346211 0.85 SIGMAR1 (0.41) SIGMAR1USP2HPGDHSD17B10MAPT
SCHEMBL17346185 0.85 DRD3 (0.47) SIGMAR1
SCHEMBL17346012 0.85 SIGMAR1 (0.38) SIGMAR1USP2HPGDHSD17B10KDM4E
SCHEMBL17346336 0.84 ACKR3 (0.43) SIGMAR1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN SIGMAR1 412/4885SLC18A3 1446/4885USP2 4424/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN SIGMAR1 412/4885SLC18A3 1446/4885USP2 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.